메뉴 건너뛰기




Volumn 1832, Issue 4, 2013, Pages 527-541

Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration

Author keywords

Alzheimer's disease; Brain; Diabetes; Glucagon like peptide 1 mimetics; Insulin signaling; Neuroprotection

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INCRETIN; INSULIN; INSULIN RECEPTOR; LEPTIN; LIRAGLUTIDE; NEUROPEPTIDE Y; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PIOGLITAZONE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; SITAGLIPTIN; SOMATOMEDIN C;

EID: 84873306844     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.01.008     Document Type: Review
Times cited : (119)

References (305)
  • 1
    • 84868282388 scopus 로고    scopus 로고
    • Insulin in central nervous system: more than just a peripheral hormone
    • Duarte A.I., Moreira P.I., Oliveira C.R. Insulin in central nervous system: more than just a peripheral hormone. J. Aging Res. 2012, 384017-384038.
    • (2012) J. Aging Res. , pp. 384017-384038
    • Duarte, A.I.1    Moreira, P.I.2    Oliveira, C.R.3
  • 2
    • 79958700336 scopus 로고    scopus 로고
    • Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus
    • Campbell R.K. Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitus. Clin. Ther. 2011, 33:511-527.
    • (2011) Clin. Ther. , vol.33 , pp. 511-527
    • Campbell, R.K.1
  • 3
    • 34249293462 scopus 로고    scopus 로고
    • International Diabetes Federation, Brussels, D. Gan (Ed.)
    • Sicree R., Shaw J., Zimmet P. Diabetes Atlas 2006, 15-103. International Diabetes Federation, Brussels. third ed. D. Gan (Ed.).
    • (2006) Diabetes Atlas , pp. 15-103
    • Sicree, R.1    Shaw, J.2    Zimmet, P.3
  • 4
    • 2342466734 scopus 로고    scopus 로고
    • Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
    • Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
    • (2004) Diabetes Care , vol.27 , pp. 1047-1053
    • Wild, S.1    Roglic, G.2    Green, A.3    Sicree, R.4    King, H.5
  • 6
    • 67649351473 scopus 로고    scopus 로고
    • (accessed August 2nd, 2012), World Health Organization
    • World Health Organization Diabetes facts, fact sheet no. 312 (accessed August 2nd, 2012). http://www.who.int/mediacentre/factsheets/fs312/en/.
    • Diabetes facts, fact sheet no. 312
  • 7
    • 84860599622 scopus 로고    scopus 로고
    • Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities
    • Carvalho C., Cardoso S., Correia S.C., Santos R.X., Santos M.S., Baldeiras I., Oliveira C.R., Moreira P.I. Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 2012, 61:1234-1242.
    • (2012) Diabetes , vol.61 , pp. 1234-1242
    • Carvalho, C.1    Cardoso, S.2    Correia, S.C.3    Santos, R.X.4    Santos, M.S.5    Baldeiras, I.6    Oliveira, C.R.7    Moreira, P.I.8
  • 9
    • 36448936053 scopus 로고    scopus 로고
    • Common pathological processes in Alzheimer disease and type 2 diabetes: a review
    • Li L., Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res. Rev. 2007, 56:384-402.
    • (2007) Brain Res. Rev. , vol.56 , pp. 384-402
    • Li, L.1    Hölscher, C.2
  • 10
    • 28444455190 scopus 로고    scopus 로고
    • The impact of diabetes on cognition: what can be learned from rodent models?
    • Biessels G.J., Gispen W.H. The impact of diabetes on cognition: what can be learned from rodent models?. Neurobiol. Aging 2005, 26:S36-S41.
    • (2005) Neurobiol. Aging , vol.26
    • Biessels, G.J.1    Gispen, W.H.2
  • 11
    • 67649687039 scopus 로고    scopus 로고
    • An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease
    • Moreira P.I., Duarte A.I., Santos M.S., Rego A.C., Oliveira C.R. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J. Alzheimers Dis. 2009, 16:741-761.
    • (2009) J. Alzheimers Dis. , vol.16 , pp. 741-761
    • Moreira, P.I.1    Duarte, A.I.2    Santos, M.S.3    Rego, A.C.4    Oliveira, C.R.5
  • 12
    • 77952350925 scopus 로고    scopus 로고
    • The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease
    • Magierski R., Kłoszewska I., Sobów T.M. The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease. Neurol. Neurochir. Pol. 2010, 44:139-147.
    • (2010) Neurol. Neurochir. Pol. , vol.44 , pp. 139-147
    • Magierski, R.1    Kłoszewska, I.2    Sobów, T.M.3
  • 13
    • 33749001980 scopus 로고    scopus 로고
    • Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT)
    • Akisaki T., Sakurai T., Takata T., Umegaki H., Araki A., Mizuno S., Tanaka S., Ohashi Y., Iguchi A., Yokono K., Ito H. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab. Res. Rev. 2006, 22:376-384.
    • (2006) Diabetes Metab. Res. Rev. , vol.22 , pp. 376-384
    • Akisaki, T.1    Sakurai, T.2    Takata, T.3    Umegaki, H.4    Araki, A.5    Mizuno, S.6    Tanaka, S.7    Ohashi, Y.8    Iguchi, A.9    Yokono, K.10    Ito, H.11
  • 20
    • 67649421600 scopus 로고    scopus 로고
    • Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus
    • Bruehl H., Wolf O.T., Sweat V., Tirsi A., Richardson S., Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res. 2009, 1280:186-194.
    • (2009) Brain Res. , vol.1280 , pp. 186-194
    • Bruehl, H.1    Wolf, O.T.2    Sweat, V.3    Tirsi, A.4    Richardson, S.5    Convit, A.6
  • 21
    • 38449088511 scopus 로고    scopus 로고
    • Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach
    • Salkovic-Petrisic M., Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J. Neural Transm. 2007, 72:217-233.
    • (2007) J. Neural Transm. , vol.72 , pp. 217-233
    • Salkovic-Petrisic, M.1    Hoyer, S.2
  • 22
    • 28444459842 scopus 로고    scopus 로고
    • Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation
    • Craft S. Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol. Aging 2005, 26(Suppl.):S65-S69.
    • (2005) Neurobiol. Aging , vol.26 , Issue.SUPPL.
    • Craft, S.1
  • 23
    • 68149112275 scopus 로고    scopus 로고
    • Insulin and the brain
    • Laron Z. Insulin and the brain. Arch. Physiol. Biochem. 2009, 115:112-116.
    • (2009) Arch. Physiol. Biochem. , vol.115 , pp. 112-116
    • Laron, Z.1
  • 24
    • 47849121436 scopus 로고    scopus 로고
    • An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease
    • Erol A. An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease. J. Alzheimers Dis. 2008, 13:241-253.
    • (2008) J. Alzheimers Dis. , vol.13 , pp. 241-253
    • Erol, A.1
  • 26
    • 1842772562 scopus 로고
    • CNS regulation of carbohydrate metabolism
    • Academic Press, A. Szabo (Ed.)
    • LeRoith D. CNS regulation of carbohydrate metabolism. Advances in Metabolic Disorders 1983, vol. 10:304-340. Academic Press. A. Szabo (Ed.).
    • (1983) Advances in Metabolic Disorders , vol.10 , pp. 304-340
    • LeRoith, D.1
  • 27
    • 0033664539 scopus 로고    scopus 로고
    • Insulin receptors and insulin action in the brain: review and clinical implications
    • Schulingkamp R.J., Pagano T.C., Hung D., Raffa R.B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 2000, 24:855-872.
    • (2000) Neurosci. Biobehav. Rev. , vol.24 , pp. 855-872
    • Schulingkamp, R.J.1    Pagano, T.C.2    Hung, D.3    Raffa, R.B.4
  • 29
    • 0041324703 scopus 로고    scopus 로고
    • Memory function and brain glucose metabolism
    • Hoyer S. Memory function and brain glucose metabolism. Pharmacopsychiatry 2003, 36:S62-S67.
    • (2003) Pharmacopsychiatry , vol.36
    • Hoyer, S.1
  • 30
    • 1642287995 scopus 로고    scopus 로고
    • Biphasic effects of stress upon GLUT8 glucose transporter expression and trafficking in the diabetic rat hippocampus
    • Piroli G.G., Grillo C.A., Charron M.J., McEwen B.S., Reagan L.P. Biphasic effects of stress upon GLUT8 glucose transporter expression and trafficking in the diabetic rat hippocampus. Brain Res. 2004, 1006:28-35.
    • (2004) Brain Res. , vol.1006 , pp. 28-35
    • Piroli, G.G.1    Grillo, C.A.2    Charron, M.J.3    McEwen, B.S.4    Reagan, L.P.5
  • 33
    • 0032572613 scopus 로고    scopus 로고
    • Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment
    • Biessels G.J., Kamal A., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 1998, 800:125-135.
    • (1998) Brain Res. , vol.800 , pp. 125-135
    • Biessels, G.J.1    Kamal, A.2    Urban, I.J.3    Spruijt, B.M.4    Erkelens, D.W.5    Gispen, W.H.6
  • 34
    • 0037118940 scopus 로고    scopus 로고
    • Hippocampal neuronal apoptosis in type 1 diabetes
    • Li Z.G., Zhang W., Grunberger G., Sima A.A. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 2002, 946:221-231.
    • (2002) Brain Res. , vol.946 , pp. 221-231
    • Li, Z.G.1    Zhang, W.2    Grunberger, G.3    Sima, A.A.4
  • 35
    • 17844388643 scopus 로고    scopus 로고
    • The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats
    • Sima A.A., Li Z.G. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 2005, 54:1497-1505.
    • (2005) Diabetes , vol.54 , pp. 1497-1505
    • Sima, A.A.1    Li, Z.G.2
  • 36
    • 34347377319 scopus 로고    scopus 로고
    • Alzheimer-like changes in rat models of spontaneous diabetes
    • Li Z.G., Zhang W., Sima A.A. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 2007, 56:1817-1824.
    • (2007) Diabetes , vol.56 , pp. 1817-1824
    • Li, Z.G.1    Zhang, W.2    Sima, A.A.3
  • 37
    • 0037112093 scopus 로고    scopus 로고
    • Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain
    • Sankar R., Thamotharan S., Shin D., Moley K.H., Devaskar S.U. Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain. Mol. Brain Res. 2002, 107:157-165.
    • (2002) Mol. Brain Res. , vol.107 , pp. 157-165
    • Sankar, R.1    Thamotharan, S.2    Shin, D.3    Moley, K.H.4    Devaskar, S.U.5
  • 39
    • 0022516633 scopus 로고
    • Insulin is released from rat brain neuronal cells in culture
    • Clarke D.W., Mudd L., Boyd F.T. Insulin is released from rat brain neuronal cells in culture. J. Neurochem. 1986, 47:831-836.
    • (1986) J. Neurochem. , vol.47 , pp. 831-836
    • Clarke, D.W.1    Mudd, L.2    Boyd, F.T.3
  • 40
    • 0018090354 scopus 로고
    • Insulin receptors are widely distributed in the central nervous system of the rat
    • Havrankova J., Roth J., Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978, 272:827-829.
    • (1978) Nature , vol.272 , pp. 827-829
    • Havrankova, J.1    Roth, J.2    Brownstein, M.3
  • 41
    • 28444493002 scopus 로고    scopus 로고
    • Factors promoting and ameliorating the development of obesity
    • Levin B.E. Factors promoting and ameliorating the development of obesity. Physiol. Behav. 2005, 86:633-639.
    • (2005) Physiol. Behav. , vol.86 , pp. 633-639
    • Levin, B.E.1
  • 43
    • 33750333087 scopus 로고    scopus 로고
    • Metabolic sensing neurons and the control of energy homeostasis
    • Metabolic sensing neurons and the control of energy homeostasis. Physiol. Behav. 2006, 89:486-489.
    • (2006) Physiol. Behav. , vol.89 , pp. 486-489
  • 44
    • 17844377864 scopus 로고    scopus 로고
    • Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans
    • Porte D., Baskin D.G., Schwartz M.W. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 2005, 54:1264-1276.
    • (2005) Diabetes , vol.54 , pp. 1264-1276
    • Porte, D.1    Baskin, D.G.2    Schwartz, M.W.3
  • 46
    • 27344446853 scopus 로고    scopus 로고
    • New twist on neuronal insulin receptor signaling in health, disease, and therapeutics
    • Wada A., Yokoo H., Yanagita T., Kobayashi H. New twist on neuronal insulin receptor signaling in health, disease, and therapeutics. J. Pharmacol. Sci. 2005, 99:128-143.
    • (2005) J. Pharmacol. Sci. , vol.99 , pp. 128-143
    • Wada, A.1    Yokoo, H.2    Yanagita, T.3    Kobayashi, H.4
  • 47
    • 33745838578 scopus 로고    scopus 로고
    • Central insulin action in energy and glucose homeostasis
    • Plum L., Belgardt B.F., Brüning J.C. Central insulin action in energy and glucose homeostasis. J. Clin. Invest. 2006, 116:1761-1766.
    • (2006) J. Clin. Invest. , vol.116 , pp. 1761-1766
    • Plum, L.1    Belgardt, B.F.2    Brüning, J.C.3
  • 49
    • 33845515150 scopus 로고    scopus 로고
    • The inhibitory effects of insulin on hepatic glucose production are both direct and indirect
    • Girard J. The inhibitory effects of insulin on hepatic glucose production are both direct and indirect. Diabetes 2006, 55:S65-S69.
    • (2006) Diabetes , vol.55
    • Girard, J.1
  • 50
    • 0034333018 scopus 로고    scopus 로고
    • Cognition and synaptic plasticity in diabetes mellitus
    • Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 2000, 23:542-549.
    • (2000) Trends Neurosci. , vol.23 , pp. 542-549
    • Gispen, W.H.1    Biessels, G.J.2
  • 52
    • 65649098029 scopus 로고    scopus 로고
    • Phosphorylation of IRS proteins, insulin action, and insulin resistance
    • Boura-Halfon S., Zick Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E581-E591.
    • (2009) Am. J. Physiol. Endocrinol. Metab. , vol.296
    • Boura-Halfon, S.1    Zick, Y.2
  • 54
    • 1842684425 scopus 로고    scopus 로고
    • Cerebral glucose metabolism in diabetes mellitus
    • McCall A.L. Cerebral glucose metabolism in diabetes mellitus. Eur. J. Pharmacol. 2004, 490:147-158.
    • (2004) Eur. J. Pharmacol. , vol.490 , pp. 147-158
    • McCall, A.L.1
  • 56
    • 0022647664 scopus 로고
    • Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain
    • Heidenreich K.A., Brandenburg D. Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain. Endocrinology 1986, 118:1835-1842.
    • (1986) Endocrinology , vol.118 , pp. 1835-1842
    • Heidenreich, K.A.1    Brandenburg, D.2
  • 57
    • 0021189287 scopus 로고
    • Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain
    • Clarke D.W., Boyd F.T., Kappy M.S., Raizada K. Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain. J. Biol. Chem. 1984, 259:11672-11675.
    • (1984) J. Biol. Chem. , vol.259 , pp. 11672-11675
    • Clarke, D.W.1    Boyd, F.T.2    Kappy, M.S.3    Raizada, K.4
  • 58
    • 0034938160 scopus 로고    scopus 로고
    • Cognitive effects of insulin in the central nervous system
    • Park C.R. Cognitive effects of insulin in the central nervous system. Neurosci. Biobehav. Rev. 2001, 25:311-323.
    • (2001) Neurosci. Biobehav. Rev. , vol.25 , pp. 311-323
    • Park, C.R.1
  • 59
    • 10644221251 scopus 로고    scopus 로고
    • Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons
    • Huang T.J., Verkhratsky A., Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol. Cell. Neurosci. 2005, 28:42-54.
    • (2005) Mol. Cell. Neurosci. , vol.28 , pp. 42-54
    • Huang, T.J.1    Verkhratsky, A.2    Fernyhough, P.3
  • 60
    • 33747379602 scopus 로고    scopus 로고
    • Brain function and insulin signal transduction in sporadic Alzheimer's disease
    • Nova Science, New York, NY, USA, M. Sich (Ed.)
    • Hoyer S., Frölich L. Brain function and insulin signal transduction in sporadic Alzheimer's disease. Research Progress in Alzheimer's Disease and Dementia 2006, 23-46. Nova Science, New York, NY, USA. M. Sich (Ed.).
    • (2006) Research Progress in Alzheimer's Disease and Dementia , pp. 23-46
    • Hoyer, S.1    Frölich, L.2
  • 61
    • 0033521130 scopus 로고    scopus 로고
    • Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats
    • Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., Alkon D.L. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 1999, 274:34893-34902.
    • (1999) J. Biol. Chem. , vol.274 , pp. 34893-34902
    • Zhao, W.1    Chen, H.2    Xu, H.3    Moore, E.4    Meiri, N.5    Quon, M.J.6    Alkon, D.L.7
  • 63
    • 1242316296 scopus 로고    scopus 로고
    • Insulin and neurodegenerative disease: shared and specific mechanisms
    • Craft S., Watson G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 2004, 3:169-178.
    • (2004) Lancet Neurol. , vol.3 , pp. 169-178
    • Craft, S.1    Watson, G.S.2
  • 64
    • 0036895563 scopus 로고    scopus 로고
    • The role of insulin in human brain glucose metabolism: an 18fluorodeoxyglucose positron emission tomography study
    • Bingham E.M., Hopkins D., Smith D., Pernet A., Hallett W., Reed L., Marsden P.K., Amiel S.A. The role of insulin in human brain glucose metabolism: an 18fluorodeoxyglucose positron emission tomography study. Diabetes 2002, 51:3384-3390.
    • (2002) Diabetes , vol.51 , pp. 3384-3390
    • Bingham, E.M.1    Hopkins, D.2    Smith, D.3    Pernet, A.4    Hallett, W.5    Reed, L.6    Marsden, P.K.7    Amiel, S.A.8
  • 65
    • 15744384348 scopus 로고    scopus 로고
    • Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production
    • Ghosh A., Yuk Y.C., Mansfield B.C., Chou J.Y. Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J. Biol. Chem. 2005, 280:11114-11119.
    • (2005) J. Biol. Chem. , vol.280 , pp. 11114-11119
    • Ghosh, A.1    Yuk, Y.C.2    Mansfield, B.C.3    Chou, J.Y.4
  • 67
    • 33750882488 scopus 로고    scopus 로고
    • Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress
    • Duarte A.I., Proença T., Oliveira C.R., Santos M.S., Rego A.C. Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 2006, 55:2863-2870.
    • (2006) Diabetes , vol.55 , pp. 2863-2870
    • Duarte, A.I.1    Proença, T.2    Oliveira, C.R.3    Santos, M.S.4    Rego, A.C.5
  • 68
    • 43549087343 scopus 로고    scopus 로고
    • Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3β signaling pathways and changes in protein expression
    • Duarte A.I., Santos P., Oliveira C.R., Santos M.S., Rego A.C. Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3β signaling pathways and changes in protein expression. Biochim. Biophys. Acta 2008, 1783:994-1002.
    • (2008) Biochim. Biophys. Acta , vol.1783 , pp. 994-1002
    • Duarte, A.I.1    Santos, P.2    Oliveira, C.R.3    Santos, M.S.4    Rego, A.C.5
  • 69
    • 0037213776 scopus 로고    scopus 로고
    • Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species
    • Koo J.R., Vaziri N.D. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int. 2003, 63:195-201.
    • (2003) Kidney Int. , vol.63 , pp. 195-201
    • Koo, J.R.1    Vaziri, N.D.2
  • 71
    • 0035488776 scopus 로고    scopus 로고
    • The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans
    • Seaquist E.R., Damberg G.S., Tkac I., Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 2001, 50:2203-2209.
    • (2001) Diabetes , vol.50 , pp. 2203-2209
    • Seaquist, E.R.1    Damberg, G.S.2    Tkac, I.3    Gruetter, R.4
  • 74
    • 3242787235 scopus 로고    scopus 로고
    • Oxidative stress affects synaptosomal γ-aminobutyric acid and glutamate transport in diabetic rats: the role of insulin
    • Duarte A.I., Santos M.S., Seiça R., Oliveira C.R. Oxidative stress affects synaptosomal γ-aminobutyric acid and glutamate transport in diabetic rats: the role of insulin. Diabetes 2004, 53:2110-2116.
    • (2004) Diabetes , vol.53 , pp. 2110-2116
    • Duarte, A.I.1    Santos, M.S.2    Seiça, R.3    Oliveira, C.R.4
  • 75
    • 0037684715 scopus 로고    scopus 로고
    • Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions
    • Duarte A.I., Santos M.S., Seiça R., Oliveira C.R. Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions. Brain Res. 2003, 977:23-30.
    • (2003) Brain Res. , vol.977 , pp. 23-30
    • Duarte, A.I.1    Santos, M.S.2    Seiça, R.3    Oliveira, C.R.4
  • 76
    • 0031907459 scopus 로고    scopus 로고
    • Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype
    • Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., Porte D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 1998, 50:164-168.
    • (1998) Neurology , vol.50 , pp. 164-168
    • Craft, S.1    Peskind, E.2    Schwartz, M.W.3    Schellenberg, G.D.4    Raskind, M.5    Porte, D.6
  • 78
    • 15244350991 scopus 로고    scopus 로고
    • Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease
    • de la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J. Alzheimers Dis. 2005, 7:45-61.
    • (2005) J. Alzheimers Dis. , vol.7 , pp. 45-61
    • de la Monte, S.M.1    Wands, J.R.2
  • 79
    • 0142026832 scopus 로고    scopus 로고
    • Potential roles of insulin and IGF-1 in Alzheimer's disease
    • Gasparini L., Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci. 2003, 26:404-406.
    • (2003) Trends Neurosci. , vol.26 , pp. 404-406
    • Gasparini, L.1    Xu, H.2
  • 80
    • 29844432266 scopus 로고    scopus 로고
    • Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis
    • Qiu W.Q., Folstein M.F. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 2006, 27:190-198.
    • (2006) Neurobiol. Aging , vol.27 , pp. 190-198
    • Qiu, W.Q.1    Folstein, M.F.2
  • 83
    • 70349567668 scopus 로고    scopus 로고
    • Cerebral proteolysis of amiloid-b peptide: relevance of insulin-degrading enzyme in Alzheimer's disease
    • Leal M.C., Fernandez-Gamba A., Morelli L., Castano E.M. Cerebral proteolysis of amiloid-b peptide: relevance of insulin-degrading enzyme in Alzheimer's disease. Medicina (B Aires) 2009, 69:466-472.
    • (2009) Medicina (B Aires) , vol.69 , pp. 466-472
    • Leal, M.C.1    Fernandez-Gamba, A.2    Morelli, L.3    Castano, E.M.4
  • 85
    • 0035871641 scopus 로고    scopus 로고
    • Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signalling
    • Gasparini L., Gouras G.K., Wang R., Gross R.S., Beal M.F., Greengard P., Xu H. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signalling. J. Neurosci. 2001, 21:2561-2570.
    • (2001) J. Neurosci. , vol.21 , pp. 2561-2570
    • Gasparini, L.1    Gouras, G.K.2    Wang, R.3    Gross, R.S.4    Beal, M.F.5    Greengard, P.6    Xu, H.7
  • 86
    • 0038187674 scopus 로고    scopus 로고
    • GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides
    • Phiel C.J., Wilson C.A., Lee V.M., Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423:435-439.
    • (2003) Nature , vol.423 , pp. 435-439
    • Phiel, C.J.1    Wilson, C.A.2    Lee, V.M.3    Klein, P.S.4
  • 87
    • 74049099554 scopus 로고    scopus 로고
    • The relationship between Alzheimer's disease and diabetes: type 3 diabetes?
    • Kroner Z. The relationship between Alzheimer's disease and diabetes: type 3 diabetes?. Altern. Med. Rev. 2009, 14:373-379.
    • (2009) Altern. Med. Rev. , vol.14 , pp. 373-379
    • Kroner, Z.1
  • 90
    • 27844537831 scopus 로고    scopus 로고
    • Tau is hyperphosphorylated in the insulin-like growth factor-I null brain
    • Cheng C.M., Tseng V., Wang J., Wang D., Matyakhina L., Bondy C.A. Tau is hyperphosphorylated in the insulin-like growth factor-I null brain. Endocrinology 2005, 146:5086-5091.
    • (2005) Endocrinology , vol.146 , pp. 5086-5091
    • Cheng, C.M.1    Tseng, V.2    Wang, J.3    Wang, D.4    Matyakhina, L.5    Bondy, C.A.6
  • 93
    • 57049125529 scopus 로고    scopus 로고
    • Defective insulin signalling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin
    • Jolivalt C.G., Lee C.A., Beiswenger K.K., Smith J.L., Orlov M., Torrance M.A., Masliah E. Defective insulin signalling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. J. Neurosci. Res. 2008, 86:3265-3274.
    • (2008) J. Neurosci. Res. , vol.86 , pp. 3265-3274
    • Jolivalt, C.G.1    Lee, C.A.2    Beiswenger, K.K.3    Smith, J.L.4    Orlov, M.5    Torrance, M.A.6    Masliah, E.7
  • 95
    • 0034638270 scopus 로고    scopus 로고
    • Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons
    • Lesort M., Johnson G.V. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience 2000, 99:305-316.
    • (2000) Neuroscience , vol.99 , pp. 305-316
    • Lesort, M.1    Johnson, G.V.2
  • 96
    • 71949112504 scopus 로고    scopus 로고
    • Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes
    • Kim B., Backus C., Oh S., Hayes J.M., Feldman E.L. Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 2009, 150:5294-5301.
    • (2009) Endocrinology , vol.150 , pp. 5294-5301
    • Kim, B.1    Backus, C.2    Oh, S.3    Hayes, J.M.4    Feldman, E.L.5
  • 97
    • 0035947044 scopus 로고    scopus 로고
    • Role of insulin and insulin receptor in learning and memory
    • Zhao W.Q., Alkon D.L. Role of insulin and insulin receptor in learning and memory. Mol. Cell. Endocrinol. 2001, 177:125-134.
    • (2001) Mol. Cell. Endocrinol. , vol.177 , pp. 125-134
    • Zhao, W.Q.1    Alkon, D.L.2
  • 99
    • 3042785971 scopus 로고    scopus 로고
    • Direct insulin signalling of neurons reverses diabetic neuropathy
    • Brussee V., Cunningham F.A., Zochodne D.W. Direct insulin signalling of neurons reverses diabetic neuropathy. Diabetes 2004, 53:1824-1830.
    • (2004) Diabetes , vol.53 , pp. 1824-1830
    • Brussee, V.1    Cunningham, F.A.2    Zochodne, D.W.3
  • 101
    • 33748295795 scopus 로고    scopus 로고
    • Insulin signaling in the central nervous system: learning to survive
    • van der Heide L.P., Ramakers G.M.J., Smidt M.P. Insulin signaling in the central nervous system: learning to survive. Prog. Neurobiol. 2006, 79:205-221.
    • (2006) Prog. Neurobiol. , vol.79 , pp. 205-221
    • van der Heide, L.P.1    Ramakers, G.M.J.2    Smidt, M.P.3
  • 102
    • 3543067962 scopus 로고    scopus 로고
    • Neurodegenetive disorders associated with diabetes mellitus
    • Ristow M. Neurodegenetive disorders associated with diabetes mellitus. J. Mol. Med. 2004, 82:510-529.
    • (2004) J. Mol. Med. , vol.82 , pp. 510-529
    • Ristow, M.1
  • 103
    • 1842734649 scopus 로고    scopus 로고
    • Modulation ofmemory by insulin and glucose: neuropsychological observations in Alzheimer's disease
    • Watson G.S., Craft S. Modulation ofmemory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur. J. Pharmacol. 2004, 490:97-113.
    • (2004) Eur. J. Pharmacol. , vol.490 , pp. 97-113
    • Watson, G.S.1    Craft, S.2
  • 105
    • 4344559467 scopus 로고    scopus 로고
    • The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function
    • Scheepers A., Joost H.G., Schurmann A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J. Parenter. Enter. Nutr. 2004, 28:364-371.
    • (2004) J. Parenter. Enter. Nutr. , vol.28 , pp. 364-371
    • Scheepers, A.1    Joost, H.G.2    Schurmann, A.3
  • 106
    • 64249129005 scopus 로고    scopus 로고
    • Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease
    • Zhao W.Q., Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim. Biophys. Acta 2009, 1792:482-496.
    • (2009) Biochim. Biophys. Acta , vol.1792 , pp. 482-496
    • Zhao, W.Q.1    Townsend, M.2
  • 107
    • 78651274000 scopus 로고    scopus 로고
    • Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes
    • Baker L.D., Cross D.J., Minoshima S., Belongia D., Watson G.S., Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch. Neurol. 2011, 68:51-57.
    • (2011) Arch. Neurol. , vol.68 , pp. 51-57
    • Baker, L.D.1    Cross, D.J.2    Minoshima, S.3    Belongia, D.4    Watson, G.S.5    Craft, S.6
  • 108
    • 33746377894 scopus 로고    scopus 로고
    • Protein misfolding, functional amyloid, and human disease
    • Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
    • (2006) Annu. Rev. Biochem. , vol.75 , pp. 333-366
    • Chiti, F.1    Dobson, C.M.2
  • 109
    • 84863002103 scopus 로고    scopus 로고
    • Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin
    • Moreira P.I. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin. J. Alzheimers Dis. 2012, 30:S199-S215.
    • (2012) J. Alzheimers Dis. , vol.30
    • Moreira, P.I.1
  • 110
    • 0037222391 scopus 로고    scopus 로고
    • Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy
    • Schmeichel A.M., Schmelzer J.D., Low P.A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003, 52:165-171.
    • (2003) Diabetes , vol.52 , pp. 165-171
    • Schmeichel, A.M.1    Schmelzer, J.D.2    Low, P.A.3
  • 111
    • 33746881744 scopus 로고    scopus 로고
    • Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1
    • Leinninger G.M., Backus C., Sastry A.M., Yi Y.B., Wang C.W., Feldman E.L. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol. Dis. 2006, 23:11-22.
    • (2006) Neurobiol. Dis. , vol.23 , pp. 11-22
    • Leinninger, G.M.1    Backus, C.2    Sastry, A.M.3    Yi, Y.B.4    Wang, C.W.5    Feldman, E.L.6
  • 114
    • 0038321341 scopus 로고    scopus 로고
    • Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-β exposure
    • Moreira P.I., Santos M.S., Moreno A.M., Seiça R., Oliveira C.R. Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-β exposure. Diabetes 2003, 52:1449-1456.
    • (2003) Diabetes , vol.52 , pp. 1449-1456
    • Moreira, P.I.1    Santos, M.S.2    Moreno, A.M.3    Seiça, R.4    Oliveira, C.R.5
  • 116
    • 77956197971 scopus 로고    scopus 로고
    • Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice
    • Dragicevic N., Mamcarz M., Zhu Y., Buzzeo R., Tan J., Arendash G.W., Bradshaw P.C. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J. Alzheimers Dis. 2010, 20(Suppl. 2):S535-S550.
    • (2010) J. Alzheimers Dis. , vol.20 , Issue.SUPPL. 2
    • Dragicevic, N.1    Mamcarz, M.2    Zhu, Y.3    Buzzeo, R.4    Tan, J.5    Arendash, G.W.6    Bradshaw, P.C.7
  • 117
    • 33746153746 scopus 로고    scopus 로고
    • Insulin attenuates diabetes-related mitochondrial alterations: a comparative study
    • Moreira P.I., Rolo A.P., Sena C., Seica R., Oliveira C.R., Santos M.S. Insulin attenuates diabetes-related mitochondrial alterations: a comparative study. Med. Chem. 2006, 2:299-308.
    • (2006) Med. Chem. , vol.2 , pp. 299-308
    • Moreira, P.I.1    Rolo, A.P.2    Sena, C.3    Seica, R.4    Oliveira, C.R.5    Santos, M.S.6
  • 119
    • 33747036919 scopus 로고    scopus 로고
    • Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics
    • Butterfield D.A., Perluigi M., Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 2006, 545:39-50.
    • (2006) Eur. J. Pharmacol. , vol.545 , pp. 39-50
    • Butterfield, D.A.1    Perluigi, M.2    Sultana, R.3
  • 120
    • 0033762782 scopus 로고    scopus 로고
    • Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes
    • Silva J.P., Kohler M., Graff C., Oldfors A., Magnuson M.A., Berggren P.O., Larsson N.G. Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat. Genet. 2000, 26:336-340.
    • (2000) Nat. Genet. , vol.26 , pp. 336-340
    • Silva, J.P.1    Kohler, M.2    Graff, C.3    Oldfors, A.4    Magnuson, M.A.5    Berggren, P.O.6    Larsson, N.G.7
  • 121
    • 26244447857 scopus 로고    scopus 로고
    • CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats
    • Moreira P.I., Santos M.S., Sena C., Nunes E., Seiça R., Oliveira C.R. CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp. Neurol. 2005, 196:112-119.
    • (2005) Exp. Neurol. , vol.196 , pp. 112-119
    • Moreira, P.I.1    Santos, M.S.2    Sena, C.3    Nunes, E.4    Seiça, R.5    Oliveira, C.R.6
  • 122
    • 14744294296 scopus 로고    scopus 로고
    • Insulin protects against amyloid β-peptide toxicity in brain mitochondria of diabetic rats
    • Moreira P.I., Santos M.S., Sena C., Seiça R., Oliveira C.R. Insulin protects against amyloid β-peptide toxicity in brain mitochondria of diabetic rats. Neurobiol. Dis. 2005, 18:628-637.
    • (2005) Neurobiol. Dis. , vol.18 , pp. 628-637
    • Moreira, P.I.1    Santos, M.S.2    Sena, C.3    Seiça, R.4    Oliveira, C.R.5
  • 124
    • 0034634237 scopus 로고    scopus 로고
    • Synaptosomes isolated from Goto-Kakizaki diabetic rat brain exhibit increased resistance to oxidative stress: role of vitamin E
    • Santos M.S., Duarte A.I., Matos M.J., Proença T., Seiça R., Oliveira C.R. Synaptosomes isolated from Goto-Kakizaki diabetic rat brain exhibit increased resistance to oxidative stress: role of vitamin E. Life Sci. 2000, 67:3061-3073.
    • (2000) Life Sci. , vol.67 , pp. 3061-3073
    • Santos, M.S.1    Duarte, A.I.2    Matos, M.J.3    Proença, T.4    Seiça, R.5    Oliveira, C.R.6
  • 127
    • 0039174315 scopus 로고    scopus 로고
    • Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation
    • Vasquez-Vivar J., Kalyanaraman B., Kennedy M.C. Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J. Biol. Chem. 2000, 275:14064-14069.
    • (2000) J. Biol. Chem. , vol.275 , pp. 14064-14069
    • Vasquez-Vivar, J.1    Kalyanaraman, B.2    Kennedy, M.C.3
  • 129
  • 133
    • 33646152108 scopus 로고    scopus 로고
    • Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression
    • Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., Reddy P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 2006, 15:1437-1449.
    • (2006) Hum. Mol. Genet. , vol.15 , pp. 1437-1449
    • Manczak, M.1    Anekonda, T.S.2    Henson, E.3    Park, B.S.4    Quinn, J.5    Reddy, P.H.6
  • 134
    • 0035917814 scopus 로고    scopus 로고
    • Mitochondrial permeability transition and oxidative stress
    • Kowaltowski A.J., Castilho R.F., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001, 495:12-15.
    • (2001) FEBS Lett. , vol.495 , pp. 12-15
    • Kowaltowski, A.J.1    Castilho, R.F.2    Vercesi, A.E.3
  • 135
    • 16344377076 scopus 로고    scopus 로고
    • Short-term hyperglycemia produces oxidative damage and apoptosis in neurons
    • Vincent A.M., McLean L.L., Backus C., Feldman E.L. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J. 2005, 19:638-640.
    • (2005) FASEB J. , vol.19 , pp. 638-640
    • Vincent, A.M.1    McLean, L.L.2    Backus, C.3    Feldman, E.L.4
  • 136
    • 14944355753 scopus 로고    scopus 로고
    • The role of impaired insulin/IGF action in primary diabetic encephalopathy
    • Li Z.G., Zhang W., Sima A.A.F. The role of impaired insulin/IGF action in primary diabetic encephalopathy. Brain Res. 2005, 1037:12-24.
    • (2005) Brain Res. , vol.1037 , pp. 12-24
    • Li, Z.G.1    Zhang, W.2    Sima, A.A.F.3
  • 138
    • 33644681565 scopus 로고    scopus 로고
    • Oxidative nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited
    • Obrosova I.G., Drel V.R., Pacher P., Ilnytska O., Wang Z.Q., Stevens M.J., Yorek M.A. Oxidative nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 2005, 54:3435-3441.
    • (2005) Diabetes , vol.54 , pp. 3435-3441
    • Obrosova, I.G.1    Drel, V.R.2    Pacher, P.3    Ilnytska, O.4    Wang, Z.Q.5    Stevens, M.J.6    Yorek, M.A.7
  • 139
    • 42049118293 scopus 로고    scopus 로고
    • Clinical review: the role of advanced glycation end products in progression and complications of Diabetes
    • Goh S.Y., Cooper M.E. Clinical review: the role of advanced glycation end products in progression and complications of Diabetes. J. Clin. Endocrinol. Metab. 2008, 93:1143-1152.
    • (2008) J. Clin. Endocrinol. Metab. , vol.93 , pp. 1143-1152
    • Goh, S.Y.1    Cooper, M.E.2
  • 142
    • 43549098757 scopus 로고    scopus 로고
    • Advanced glycation: implications in tissue damage and disease
    • Gasser A., Forbes J.M. Advanced glycation: implications in tissue damage and disease. Protein Pept. Lett. 2008, 15:385-391.
    • (2008) Protein Pept. Lett. , vol.15 , pp. 385-391
    • Gasser, A.1    Forbes, J.M.2
  • 143
    • 0021043112 scopus 로고
    • Effects of hypoglycemia on the transmitter pool and the metabolic pool of glutamate in rat brain
    • Engelsen B., Fonnum F. Effects of hypoglycemia on the transmitter pool and the metabolic pool of glutamate in rat brain. Neurosci. Lett. 1983, 42:317-322.
    • (1983) Neurosci. Lett. , vol.42 , pp. 317-322
    • Engelsen, B.1    Fonnum, F.2
  • 145
    • 0031732043 scopus 로고    scopus 로고
    • Comparison of lactate and glucose metabolism in cultured neocortical neurons and astrocytes using 13C-NMR spectroscopy
    • Waagepetersen H.S., Bakken I.J., Larsson O.M., Sonnewald U., Schousboe A. Comparison of lactate and glucose metabolism in cultured neocortical neurons and astrocytes using 13C-NMR spectroscopy. Dev. Neurosci. 1998, 20:310-320.
    • (1998) Dev. Neurosci. , vol.20 , pp. 310-320
    • Waagepetersen, H.S.1    Bakken, I.J.2    Larsson, O.M.3    Sonnewald, U.4    Schousboe, A.5
  • 146
    • 79953276927 scopus 로고    scopus 로고
    • Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters
    • Cardoso S., Carvalho C., Santos R., Correia S., Santos M.S., Seiça R., Oliveira C.R., Moreira P.I. Impact of STZ-induced hyperglycemia and insulin-induced hypoglycemia in plasma amino acids and cortical synaptosomal neurotransmitters. Synapse 2011, 65:457-466.
    • (2011) Synapse , vol.65 , pp. 457-466
    • Cardoso, S.1    Carvalho, C.2    Santos, R.3    Correia, S.4    Santos, M.S.5    Seiça, R.6    Oliveira, C.R.7    Moreira, P.I.8
  • 147
    • 33745893228 scopus 로고    scopus 로고
    • The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer
    • Bak L.K., Schousboe A., Waagepetersen H.S. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 2006, 98:641-653.
    • (2006) J. Neurochem. , vol.98 , pp. 641-653
    • Bak, L.K.1    Schousboe, A.2    Waagepetersen, H.S.3
  • 148
    • 46349091157 scopus 로고    scopus 로고
    • Tissue specificity of mitochondrial glutamate pathways and the control of metabolic homeostasis
    • Frigerio F., Casimir M., Carobbio S., Maechler P. Tissue specificity of mitochondrial glutamate pathways and the control of metabolic homeostasis. Biochim. Biophys. Acta 2008, 1777:965-972.
    • (2008) Biochim. Biophys. Acta , vol.1777 , pp. 965-972
    • Frigerio, F.1    Casimir, M.2    Carobbio, S.3    Maechler, P.4
  • 150
    • 0034725819 scopus 로고    scopus 로고
    • The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia
    • Guyot L.L., Diaz F.G., O'Regan M.H., Song D., Phillis J.W. The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia. Brain Res. 2000, 872:29-36.
    • (2000) Brain Res. , vol.872 , pp. 29-36
    • Guyot, L.L.1    Diaz, F.G.2    O'Regan, M.H.3    Song, D.4    Phillis, J.W.5
  • 151
    • 0033533078 scopus 로고    scopus 로고
    • Effect of hyperglycemia on extracellular levels of amino acids and free fatty acids in the ischemic/reperfused rat cerebral cortex
    • Phillis J.W., Song D., O'Regan M.H. Effect of hyperglycemia on extracellular levels of amino acids and free fatty acids in the ischemic/reperfused rat cerebral cortex. Brain Res. 1999, 837:177-183.
    • (1999) Brain Res. , vol.837 , pp. 177-183
    • Phillis, J.W.1    Song, D.2    O'Regan, M.H.3
  • 152
    • 0034055119 scopus 로고    scopus 로고
    • Topical insulin and accumulation of excitotoxic and other amino acids in ischemic rat cerebral cortex
    • Guyot L.L., Diaz F.G., O'Regan M.H., Song D., Phillis J.W. Topical insulin and accumulation of excitotoxic and other amino acids in ischemic rat cerebral cortex. Exp. Biol. Med. 2000, 224:28-31.
    • (2000) Exp. Biol. Med. , vol.224 , pp. 28-31
    • Guyot, L.L.1    Diaz, F.G.2    O'Regan, M.H.3    Song, D.4    Phillis, J.W.5
  • 154
    • 0029919399 scopus 로고    scopus 로고
    • Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium
    • Vilchis C., Salceda R. Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium. Neurochem. Res. 1996, 21:1167-1171.
    • (1996) Neurochem. Res. , vol.21 , pp. 1167-1171
    • Vilchis, C.1    Salceda, R.2
  • 155
    • 41149118419 scopus 로고    scopus 로고
    • Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse
    • Beauquis J., Saravia F., Coulaud J., Roig P., Dardenne M., Homo-Delarche F., De Nicola A. Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse. Exp. Neurol. 2008, 210:359-367.
    • (2008) Exp. Neurol. , vol.210 , pp. 359-367
    • Beauquis, J.1    Saravia, F.2    Coulaud, J.3    Roig, P.4    Dardenne, M.5    Homo-Delarche, F.6    De Nicola, A.7
  • 156
    • 39749137437 scopus 로고    scopus 로고
    • Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons
    • Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 2008, 11:309-317.
    • (2008) Nat. Neurosci. , vol.11 , pp. 309-317
    • Stranahan, A.M.1    Arumugam, T.V.2    Cutler, R.G.3    Lee, K.4    Egan, J.M.5    Mattson, M.P.6
  • 157
    • 38849186635 scopus 로고    scopus 로고
    • Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats
    • Zhang W.J., Tan Y.F., Yue J.T., Vranic M., Wojtowicz J.M. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol. Scand. 2008, 117:205-210.
    • (2008) Acta Neurol. Scand. , vol.117 , pp. 205-210
    • Zhang, W.J.1    Tan, Y.F.2    Yue, J.T.3    Vranic, M.4    Wojtowicz, J.M.5
  • 158
    • 64849111978 scopus 로고    scopus 로고
    • Impaired neurogenesis in adult type-2 diabetic rats
    • Lang B.T., Yan Y., Dempsey R.J., Vemuganti R. Impaired neurogenesis in adult type-2 diabetic rats. Brain Res. 2009, 3:25-33.
    • (2009) Brain Res. , vol.3 , pp. 25-33
    • Lang, B.T.1    Yan, Y.2    Dempsey, R.J.3    Vemuganti, R.4
  • 160
    • 79751479118 scopus 로고    scopus 로고
    • Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
    • Hamilton A., Patterson S., Porter D., Gault V.A., Holscher C. Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J. Neurosci. Res. 2011, 89:481-489.
    • (2011) J. Neurosci. Res. , vol.89 , pp. 481-489
    • Hamilton, A.1    Patterson, S.2    Porter, D.3    Gault, V.A.4    Holscher, C.5
  • 161
    • 34250790081 scopus 로고    scopus 로고
    • Repairing brain after stroke: a review on post-ischemic neurogenesis
    • Wiltrout C., Lang B., Yan Y., Dempsey R.J., Vemuganti R. Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem. Int. 2007, 50:1028-1041.
    • (2007) Neurochem. Int. , vol.50 , pp. 1028-1041
    • Wiltrout, C.1    Lang, B.2    Yan, Y.3    Dempsey, R.J.4    Vemuganti, R.5
  • 162
    • 42449130907 scopus 로고    scopus 로고
    • Inflammation: a new candidate in modulating adult neurogenesis
    • Das S., Basu A. Inflammation: a new candidate in modulating adult neurogenesis. J. Neurosci. Res. 2008, 86:1199-1208.
    • (2008) J. Neurosci. Res. , vol.86 , pp. 1199-1208
    • Das, S.1    Basu, A.2
  • 163
    • 59349110661 scopus 로고    scopus 로고
    • Brain inflammation and adult neurogenesis: the dual role of microglia
    • Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2008, 10.1016/j.neuroscience.2008.06.052.
    • (2008) Neuroscience
    • Ekdahl, C.T.1    Kokaia, Z.2    Lindvall, O.3
  • 164
    • 41449111462 scopus 로고    scopus 로고
    • Diabetes and cognitive decline: are steroids the missing link?
    • MacLullich A.M.J., Seckl J.R. Diabetes and cognitive decline: are steroids the missing link?. Cell Metab. 2008, 7:286-287.
    • (2008) Cell Metab. , vol.7 , pp. 286-287
    • MacLullich, A.M.J.1    Seckl, J.R.2
  • 165
    • 28444433338 scopus 로고    scopus 로고
    • Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging
    • Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol. Aging 2005, 26:S26-S30.
    • (2005) Neurobiol. Aging , vol.26
    • Messier, C.1
  • 166
    • 0032457031 scopus 로고    scopus 로고
    • Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats
    • Oitzl M.S., Fluttert M., Sutanto W., de Kloet E.R. Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur. J. Neurosci. 1998, 10:3759-3766.
    • (1998) Eur. J. Neurosci. , vol.10 , pp. 3759-3766
    • Oitzl, M.S.1    Fluttert, M.2    Sutanto, W.3    de Kloet, E.R.4
  • 167
    • 45149104267 scopus 로고    scopus 로고
    • Cognitive dysfunction and diabetes mellitus
    • Kodl C.T., Seaquist E.R. Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 2008, 29:494-511.
    • (2008) Endocr. Rev. , vol.29 , pp. 494-511
    • Kodl, C.T.1    Seaquist, E.R.2
  • 168
    • 33644756798 scopus 로고    scopus 로고
    • Cumulative activation of Akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons
    • Johnson-Farley N.N., Travkina T., Cowen D.S. Cumulative activation of Akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 2006, 316:1062-1069.
    • (2006) J. Pharmacol. Exp. Ther. , vol.316 , pp. 1062-1069
    • Johnson-Farley, N.N.1    Travkina, T.2    Cowen, D.S.3
  • 169
    • 4344571818 scopus 로고    scopus 로고
    • Impact of hypoglycaemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage
    • Singh P., Jain A., Kaur G. Impact of hypoglycaemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol. Cell. Biochem. 2004, 260:153-159.
    • (2004) Mol. Cell. Biochem. , vol.260 , pp. 153-159
    • Singh, P.1    Jain, A.2    Kaur, G.3
  • 170
    • 0032983666 scopus 로고    scopus 로고
    • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)
    • Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). J. Am. Med. Assoc. 1999, 281:2005-2012.
    • (1999) J. Am. Med. Assoc. , vol.281 , pp. 2005-2012
    • Turner, R.C.1    Cull, C.A.2    Frighi, V.3    Holman, R.R.4
  • 171
    • 5444244399 scopus 로고    scopus 로고
    • Hypoglycemic brain damage
    • Auer R.N. Hypoglycemic brain damage. Metab. Brain Dis. 2004, 19:169-175.
    • (2004) Metab. Brain Dis. , vol.19 , pp. 169-175
    • Auer, R.N.1
  • 172
    • 34547783158 scopus 로고    scopus 로고
    • Hypoglycemia, brain energetics, and hypoglycemic neuronal death
    • Suh S.W., Hamby A.M., Swanson R.A. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007, 55:1280-1286.
    • (2007) Glia , vol.55 , pp. 1280-1286
    • Suh, S.W.1    Hamby, A.M.2    Swanson, R.A.3
  • 173
    • 77956710094 scopus 로고    scopus 로고
    • Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia
    • Cardoso S., Santos M.S., Seiça R., Moreira P.I. Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia. Biochim. Biophys. Acta 2010, 1802:942-951.
    • (2010) Biochim. Biophys. Acta , vol.1802 , pp. 942-951
    • Cardoso, S.1    Santos, M.S.2    Seiça, R.3    Moreira, P.I.4
  • 175
    • 0033863049 scopus 로고    scopus 로고
    • Effect of hypoglycemia on amino acid and protein metabolism in healthy humans
    • Battezzati A., Benedini S., Fattorini A., Piceni Sereni L., Luzi L. Effect of hypoglycemia on amino acid and protein metabolism in healthy humans. Diabetes 2000, 49:1543-1551.
    • (2000) Diabetes , vol.49 , pp. 1543-1551
    • Battezzati, A.1    Benedini, S.2    Fattorini, A.3    Piceni Sereni, L.4    Luzi, L.5
  • 177
    • 0027309463 scopus 로고
    • Membrane lipid peroxidation induces changes in aminobutyric acid transport and calcium uptake by synaptosomes
    • Palmeira C.M., Santos M.S., Carvalho A.P., Oliveira C.R. Membrane lipid peroxidation induces changes in aminobutyric acid transport and calcium uptake by synaptosomes. Brain Res. 1993, 609:117-123.
    • (1993) Brain Res. , vol.609 , pp. 117-123
    • Palmeira, C.M.1    Santos, M.S.2    Carvalho, A.P.3    Oliveira, C.R.4
  • 178
    • 0033232908 scopus 로고    scopus 로고
    • Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress
    • Sah R., Schwartz-Bloom R.D. Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress. J. Neurosci. 1999, 19:9209-9217.
    • (1999) J. Neurosci. , vol.19 , pp. 9209-9217
    • Sah, R.1    Schwartz-Bloom, R.D.2
  • 179
    • 0032913210 scopus 로고    scopus 로고
    • Alanine release from the adult and developing hippocampus is enhanced by ionotropic glutamate receptor agonists and cell-damaging conditions
    • Saransaari P., Oja S.S. Alanine release from the adult and developing hippocampus is enhanced by ionotropic glutamate receptor agonists and cell-damaging conditions. Neurochem. Res. 1999, 24:407-414.
    • (1999) Neurochem. Res. , vol.24 , pp. 407-414
    • Saransaari, P.1    Oja, S.S.2
  • 180
    • 84867577041 scopus 로고    scopus 로고
    • Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease byexendin-4
    • (PMID: 21901364)
    • Chen S., Liu A.R., An F.M., Yao W.B., Gao X.D. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease byexendin-4. Age (Dordr) 2012, 34:1211-1224. (PMID: 21901364).
    • (2012) Age (Dordr) , vol.34 , pp. 1211-1224
    • Chen, S.1    Liu, A.R.2    An, F.M.3    Yao, W.B.4    Gao, X.D.5
  • 182
    • 60449089649 scopus 로고    scopus 로고
    • For the American Diabetes Association; European Association for the Study of Diabetes, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., Zinman B. for the American Diabetes Association; European Association for the Study of Diabetes, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203.
    • (2009) Diabetes Care , vol.32 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Ferrannini, E.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7
  • 184
    • 58149401447 scopus 로고    scopus 로고
    • Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation
    • Cimini A., Cerù M.P. Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation. Stem Cell Rev. 2008, 4:293-303.
    • (2008) Stem Cell Rev. , vol.4 , pp. 293-303
    • Cimini, A.1    Cerù, M.P.2
  • 185
    • 33947204503 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents
    • Tureyen K., Kapadia R., Bowen K.K., Satriotomo I., Liang J., Feinstein D.L., Vemuganti R. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 2007, 101:41-56.
    • (2007) J. Neurochem. , vol.101 , pp. 41-56
    • Tureyen, K.1    Kapadia, R.2    Bowen, K.K.3    Satriotomo, I.4    Liang, J.5    Feinstein, D.L.6    Vemuganti, R.7
  • 187
    • 0034678773 scopus 로고    scopus 로고
    • Combining insulin and oral agents
    • Buse J. Combining insulin and oral agents. Am. J. Med. 2000, 108:23-32.
    • (2000) Am. J. Med. , vol.108 , pp. 23-32
    • Buse, J.1
  • 188
    • 84868283342 scopus 로고    scopus 로고
    • Pathophysiology of type 2 diabetes: a quartet of abnormalities
    • W.A. Hsueh, L.M. Moore, M. Bryer-Ash (Eds.) Contemporary Diagnosis and Management of Type 2 Diabetes
    • Hsueh W.A., Moore L.M., Bryer-Ash M. Pathophysiology of type 2 diabetes: a quartet of abnormalities. Handbooks in Health Care, Newtown, Pa, USA 2004, 5-19. W.A. Hsueh, L.M. Moore, M. Bryer-Ash (Eds.).
    • (2004) Handbooks in Health Care, Newtown, Pa, USA , pp. 5-19
    • Hsueh, W.A.1    Moore, L.M.2    Bryer-Ash, M.3
  • 189
    • 48049112843 scopus 로고    scopus 로고
    • More choices than ever before: emerging therapies for type 2 diabetes
    • Campbell R.K., White J.R. More choices than ever before: emerging therapies for type 2 diabetes. Diabetes Educ. 2008, 34:518-534.
    • (2008) Diabetes Educ. , vol.34 , pp. 518-534
    • Campbell, R.K.1    White, J.R.2
  • 190
    • 33845344395 scopus 로고
    • Plasma insulin response to oral and intravenous glucose administration
    • Elrick H., Stimmler L., Hlad C.J., Arai Y. Plasma insulin response to oral and intravenous glucose administration. J. Clin. Endocrinol. Metab. 1964, 24:1076-1082.
    • (1964) J. Clin. Endocrinol. Metab. , vol.24 , pp. 1076-1082
    • Elrick, H.1    Stimmler, L.2    Hlad, C.J.3    Arai, Y.4
  • 191
    • 33846006173 scopus 로고    scopus 로고
    • The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    • Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 192
    • 1842855423 scopus 로고    scopus 로고
    • Incretins, insulin secretion and type 2 diabetes mellitus
    • Vilsbøll T., Holst J.J. Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 2004, 47:357-366.
    • (2004) Diabetologia , vol.47 , pp. 357-366
    • Vilsbøll, T.1    Holst, J.J.2
  • 194
    • 0034880691 scopus 로고    scopus 로고
    • Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
    • Toft-Nielsen M.B., Madsbad S., Holst J.J. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. J. Clin. Endocrinol. 2001, 86:3853-3860.
    • (2001) J. Clin. Endocrinol. , vol.86 , pp. 3853-3860
    • Toft-Nielsen, M.B.1    Madsbad, S.2    Holst, J.J.3
  • 195
    • 34447267513 scopus 로고    scopus 로고
    • Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis
    • Amori R.E., Lau J., Pittas A.G. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 2007, 298:194-206.
    • (2007) JAMA , vol.298 , pp. 194-206
    • Amori, R.E.1    Lau, J.2    Pittas, A.G.3
  • 196
    • 0029118049 scopus 로고
    • Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase-IV
    • Kieffer T.J., McIntosh C.H., Pederson R.A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase-IV. Endocrinology 1995, 136:3585-3596.
    • (1995) Endocrinology , vol.136 , pp. 3585-3596
    • Kieffer, T.J.1    McIntosh, C.H.2    Pederson, R.A.3
  • 198
    • 0031908130 scopus 로고    scopus 로고
    • The structure and function of CD26 in the T-cell immune response
    • Morimoto C., Schlossman S.F. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 1998, 161:55-70.
    • (1998) Immunol. Rev. , vol.161 , pp. 55-70
    • Morimoto, C.1    Schlossman, S.F.2
  • 200
  • 201
    • 38449111196 scopus 로고    scopus 로고
    • Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice
    • Lamont B.J., Drucker D.J. Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice. Diabetes 2008, 57:190-198.
    • (2008) Diabetes , vol.57 , pp. 190-198
    • Lamont, B.J.1    Drucker, D.J.2
  • 202
    • 80052645534 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 analogues for type 2 diabetes mellitus: current and emerging agents
    • Gallwitz B. Glucagon-like peptide-1 analogues for type 2 diabetes mellitus: current and emerging agents. Drugs 2011, 71:1675-1688.
    • (2011) Drugs , vol.71 , pp. 1675-1688
    • Gallwitz, B.1
  • 203
    • 67651173077 scopus 로고    scopus 로고
    • Incretin-based therapies for type 2 diabetes mellitus
    • Lovshin J.A., Drucker D.J. Incretin-based therapies for type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2009, 5:262-269.
    • (2009) Nat. Rev. Endocrinol. , vol.5 , pp. 262-269
    • Lovshin, J.A.1    Drucker, D.J.2
  • 204
    • 55549136417 scopus 로고    scopus 로고
    • Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study
    • DeFronzo R.A., Okerson T., Viswanathan P., Guan X., Holcombe J.H., MacConell L. Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study. Curr. Med. Res. Opin. 2008, 24:2943-2952.
    • (2008) Curr. Med. Res. Opin. , vol.24 , pp. 2943-2952
    • DeFronzo, R.A.1    Okerson, T.2    Viswanathan, P.3    Guan, X.4    Holcombe, J.H.5    MacConell, L.6
  • 205
    • 77955573674 scopus 로고    scopus 로고
    • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
    • DURATION-2 Study Group
    • Bergenstal R.M., Wysham C., Macconell L., Malloy J., Walsh B., Yan P., Wilhelm K., Malone J., Porter L.E., DURATION-2 Study Group Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. Lancet 2010, 376:431-439.
    • (2010) Lancet , vol.376 , pp. 431-439
    • Bergenstal, R.M.1    Wysham, C.2    Macconell, L.3    Malloy, J.4    Walsh, B.5    Yan, P.6    Wilhelm, K.7    Malone, J.8    Porter, L.E.9
  • 206
    • 77952309372 scopus 로고    scopus 로고
    • Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycemic control with metformin: a 26-week, randomized, parallelgroup, open-label trial
    • 1860-LIRA-DPP-4 Study Group
    • Pratley R.E., Nauck M., Bailey T., Montanya E., Cuddihy R., Filetti S., Thomsen A.B., Søndergaard R.E., Davies M., 1860-LIRA-DPP-4 Study Group Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycemic control with metformin: a 26-week, randomized, parallelgroup, open-label trial. Lancet 2010, 375:1447-1456.
    • (2010) Lancet , vol.375 , pp. 1447-1456
    • Pratley, R.E.1    Nauck, M.2    Bailey, T.3    Montanya, E.4    Cuddihy, R.5    Filetti, S.6    Thomsen, A.B.7    Søndergaard, R.E.8    Davies, M.9
  • 208
    • 34250635159 scopus 로고    scopus 로고
    • GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting
    • Körner M., Stöckli M., Waser B., Reubi J.C. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J. Nucl. Med. 2007, 48:736-743.
    • (2007) J. Nucl. Med. , vol.48 , pp. 736-743
    • Körner, M.1    Stöckli, M.2    Waser, B.3    Reubi, J.C.4
  • 209
    • 69549128161 scopus 로고    scopus 로고
    • Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
    • Hamilton A., Hölscher C. Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system. Neuroreport 2009, 20:1161-1166.
    • (2009) Neuroreport , vol.20 , pp. 1161-1166
    • Hamilton, A.1    Hölscher, C.2
  • 211
    • 57649234120 scopus 로고    scopus 로고
    • The incretin system and its role in type 2 diabetes mellitus
    • Holst J.J., Vilsbøll T., Deacon C.F. The incretin system and its role in type 2 diabetes mellitus. Mol. Cell. Endocrinol. 2009, 297:127-136.
    • (2009) Mol. Cell. Endocrinol. , vol.297 , pp. 127-136
    • Holst, J.J.1    Vilsbøll, T.2    Deacon, C.F.3
  • 212
    • 0026027919 scopus 로고
    • Proglucagon products in plasma of non insulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine
    • Orskov C., Jeppesen J., Madsbad S., Holst J.J. Proglucagon products in plasma of non insulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J. Clin. Invest. 1991, 87:415-423.
    • (1991) J. Clin. Invest. , vol.87 , pp. 415-423
    • Orskov, C.1    Jeppesen, J.2    Madsbad, S.3    Holst, J.J.4
  • 213
    • 0026596851 scopus 로고
    • Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus
    • Gutniak M., Orskov C., Holst J.J., Ahrén B., Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 1992, 336:1316-1322.
    • (1992) N. Engl. J. Med. , vol.336 , pp. 1316-1322
    • Gutniak, M.1    Orskov, C.2    Holst, J.J.3    Ahrén, B.4    Efendic, S.5
  • 214
    • 0037045845 scopus 로고    scopus 로고
    • Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study
    • Zander M., Madsbad S., Madsen J.L., Holst J.J. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 2002, 359:824-830.
    • (2002) Lancet , vol.359 , pp. 824-830
    • Zander, M.1    Madsbad, S.2    Madsen, J.L.3    Holst, J.J.4
  • 215
    • 0035462466 scopus 로고    scopus 로고
    • Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA), Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men
    • Rask E., Olsson T., Söderberg S., Johnson O., Seckl J., Holst J.J., Ahrén B. Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA), Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 2001, 24:1640-1645.
    • (2001) Diabetes Care , vol.24 , pp. 1640-1645
    • Rask, E.1    Olsson, T.2    Söderberg, S.3    Johnson, O.4    Seckl, J.5    Holst, J.J.6    Ahrén, B.7
  • 216
    • 2342642148 scopus 로고    scopus 로고
    • Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance
    • Rask E., Olsson T., Söderberg S., Holst J.J., Tura A., Pacini G., Ahrén B. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism 2004, 53:624-631.
    • (2004) Metabolism , vol.53 , pp. 624-631
    • Rask, E.1    Olsson, T.2    Söderberg, S.3    Holst, J.J.4    Tura, A.5    Pacini, G.6    Ahrén, B.7
  • 217
    • 48449093468 scopus 로고    scopus 로고
    • Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients
    • Muscelli E., Mari A., Casolaro A., Camastra S., Seghieri G., Gastaldelli A., Holst J.J., Ferrannini E. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 2008, 57:1340-1348.
    • (2008) Diabetes , vol.57 , pp. 1340-1348
    • Muscelli, E.1    Mari, A.2    Casolaro, A.3    Camastra, S.4    Seghieri, G.5    Gastaldelli, A.6    Holst, J.J.7    Ferrannini, E.8
  • 218
    • 84865601559 scopus 로고    scopus 로고
    • Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia
    • Herzberg-Schäfer S., Heni M., Stefan N., Häring H.U., Fritsche A. Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia. Diabetes Obes. Metab. 2012, 14:85-90.
    • (2012) Diabetes Obes. Metab. , vol.14 , pp. 85-90
    • Herzberg-Schäfer, S.1    Heni, M.2    Stefan, N.3    Häring, H.U.4    Fritsche, A.5
  • 220
    • 84866553794 scopus 로고    scopus 로고
    • Impaired secretion of total glucagon-like peptide 1 in people with impaired fastingglucose combined impaired glucose tolerance
    • Zhang F., Tang X., Cao H., Lü Q., Li N., Liu Y., Zhang X., Zhang Y., Cao M., Wan J., An Z., Tong N. Impaired secretion of total glucagon-like peptide 1 in people with impaired fastingglucose combined impaired glucose tolerance. Int. J. Med. Sci. 2012, 9:574-581.
    • (2012) Int. J. Med. Sci. , vol.9 , pp. 574-581
    • Zhang, F.1    Tang, X.2    Cao, H.3    Lü, Q.4    Li, N.5    Liu, Y.6    Zhang, X.7    Zhang, Y.8    Cao, M.9    Wan, J.10    An, Z.11    Tong, N.12
  • 221
    • 0001095690 scopus 로고    scopus 로고
    • Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients
    • Vilsbøll T., Krarup T., Deacon C.F., Madsbad S., Holst J.J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001, 50:609-613.
    • (2001) Diabetes , vol.50 , pp. 609-613
    • Vilsbøll, T.1    Krarup, T.2    Deacon, C.F.3    Madsbad, S.4    Holst, J.J.5
  • 222
    • 77649228014 scopus 로고    scopus 로고
    • Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes
    • Lee S., Yabe D., Nohtomi K., Takada M., Morita R., Seino Y., Hirano T. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr. J. 2010, 7:119-126.
    • (2010) Endocr. J. , vol.7 , pp. 119-126
    • Lee, S.1    Yabe, D.2    Nohtomi, K.3    Takada, M.4    Morita, R.5    Seino, Y.6    Hirano, T.7
  • 223
    • 40949090627 scopus 로고    scopus 로고
    • Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance
    • Vollmer K., Holst J.J., Baller B., Ellrichmann M., Nauck M.A., Schmidt W.E., Meier J.J. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008, 57:678-687.
    • (2008) Diabetes , vol.57 , pp. 678-687
    • Vollmer, K.1    Holst, J.J.2    Baller, B.3    Ellrichmann, M.4    Nauck, M.A.5    Schmidt, W.E.6    Meier, J.J.7
  • 224
    • 79952310049 scopus 로고    scopus 로고
    • Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
    • Nauck A.M., Vardarli I., Deacon F.C., Holst J.J., Meier J.J. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?. Diabetologia 2011, 54:10-18.
    • (2011) Diabetologia , vol.54 , pp. 10-18
    • Nauck, A.M.1    Vardarli, I.2    Deacon, F.C.3    Holst, J.J.4    Meier, J.J.5
  • 227
    • 79958717389 scopus 로고    scopus 로고
    • Contrasting actions of sitagliptin and exenatide on food intake, body weight, glucose stimulated insulin secretion and gastric emptying in rodents (abstract no. 0576)
    • Gedulin B., Tatarkiewicz K., Smith P., Wilson J., Bhole D., Kendall D., Hargrove D., Parkes D. Contrasting actions of sitagliptin and exenatide on food intake, body weight, glucose stimulated insulin secretion and gastric emptying in rodents (abstract no. 0576). Diabetologia 2007, 50(Suppl. 1):S239.
    • (2007) Diabetologia , vol.50 , Issue.SUPPL. 1
    • Gedulin, B.1    Tatarkiewicz, K.2    Smith, P.3    Wilson, J.4    Bhole, D.5    Kendall, D.6    Hargrove, D.7    Parkes, D.8
  • 228
    • 0036198285 scopus 로고    scopus 로고
    • Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    • Kastin A.J., Akerstrom V., Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J. Mol. Neurosci. 2002, 18:7-14.
    • (2002) J. Mol. Neurosci. , vol.18 , pp. 7-14
    • Kastin, A.J.1    Akerstrom, V.2    Pan, W.3
  • 232
    • 78649385516 scopus 로고    scopus 로고
    • The role of GLP-1 in neuronal activity and neurodegeneration
    • Hölscher C. The role of GLP-1 in neuronal activity and neurodegeneration. Vitam. Horm. 2010, 84:331-354.
    • (2010) Vitam. Horm. , vol.84 , pp. 331-354
    • Hölscher, C.1
  • 233
    • 79951626557 scopus 로고    scopus 로고
    • Neuroprotective properties of GLP-1: theoretical and practical applications
    • Holst J.J., Burcelin R., Nathanson E. Neuroprotective properties of GLP-1: theoretical and practical applications. Curr. Med. Res. Opin. 2011, 27:547-558.
    • (2011) Curr. Med. Res. Opin. , vol.27 , pp. 547-558
    • Holst, J.J.1    Burcelin, R.2    Nathanson, E.3
  • 234
    • 78649745810 scopus 로고    scopus 로고
    • The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test
    • Isacson R., Nielsen E., Dannaeus K., Bertilsson G., Patrone C., Zachrisson O., Wikström L. The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. Eur. J. Pharmacol. 2011, 650:249-255.
    • (2011) Eur. J. Pharmacol. , vol.650 , pp. 249-255
    • Isacson, R.1    Nielsen, E.2    Dannaeus, K.3    Bertilsson, G.4    Patrone, C.5    Zachrisson, O.6    Wikström, L.7
  • 236
    • 69549138878 scopus 로고    scopus 로고
    • Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
    • Abbas T., Faivre E., Hölscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav. Brain Res. 2009, 205:265-271.
    • (2009) Behav. Brain Res. , vol.205 , pp. 265-271
    • Abbas, T.1    Faivre, E.2    Hölscher, C.3
  • 237
    • 0037349072 scopus 로고    scopus 로고
    • Entry of exendin-4 into brain is rapid but may be limited at high doses
    • Kastin A.J., Akerstrom V. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int. J. Obes. Relat. Metab. Disord. 2003, 27:313-318.
    • (2003) Int. J. Obes. Relat. Metab. Disord. , vol.27 , pp. 313-318
    • Kastin, A.J.1    Akerstrom, V.2
  • 238
    • 2142750158 scopus 로고    scopus 로고
    • Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration
    • Banks W.A., During M.J., Niehoff M.L. Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. J. Pharmacol. Exp. Ther. 2004, 309:469-475.
    • (2004) J. Pharmacol. Exp. Ther. , vol.309 , pp. 469-475
    • Banks, W.A.1    During, M.J.2    Niehoff, M.L.3
  • 239
    • 0036182251 scopus 로고    scopus 로고
    • A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells
    • Perry T., Lahiri D.K., Chen D., Zhou J., Shaw K.T., Egan J.M., Greig N.H. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. J. Pharmacol. Exp. Ther. 2002, 300:958-966.
    • (2002) J. Pharmacol. Exp. Ther. , vol.300 , pp. 958-966
    • Perry, T.1    Lahiri, D.K.2    Chen, D.3    Zhou, J.4    Shaw, K.T.5    Egan, J.M.6    Greig, N.H.7
  • 241
    • 77953094551 scopus 로고    scopus 로고
    • Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells
    • Li Y., Tweedie D., Mattson M.P., Holloway H.W., Greig N.H. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. J. Neurochem. 2010, 113:1621-1631.
    • (2010) J. Neurochem. , vol.113 , pp. 1621-1631
    • Li, Y.1    Tweedie, D.2    Mattson, M.P.3    Holloway, H.W.4    Greig, N.H.5
  • 242
    • 33744996917 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
    • Iwai T., Ito S., Tanimitsu K., Udagawa S., Oka J. Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes. Neurosci. Res. 2006, 55:352-360.
    • (2006) Neurosci. Res. , vol.55 , pp. 352-360
    • Iwai, T.1    Ito, S.2    Tanimitsu, K.3    Udagawa, S.4    Oka, J.5
  • 243
    • 70349334516 scopus 로고    scopus 로고
    • Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
    • Kim S., Moon M., Park S. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease. J. Endocrinol. 2009, 202:431-439.
    • (2009) J. Endocrinol. , vol.202 , pp. 431-439
    • Kim, S.1    Moon, M.2    Park, S.3
  • 244
    • 77958052010 scopus 로고    scopus 로고
    • A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
    • Hattori Y., Jojima T., Tomizawa A., Satoh H., Hattori S., Kasai K., Hayashi T. A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells. Diabetologia 2010, 53:2256-2266.
    • (2010) Diabetologia , vol.53 , pp. 2256-2266
    • Hattori, Y.1    Jojima, T.2    Tomizawa, A.3    Satoh, H.4    Hattori, S.5    Kasai, K.6    Hayashi, T.7
  • 245
    • 22144491473 scopus 로고    scopus 로고
    • Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease
    • Perry T., Greig N.H. Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease. Curr. Alzheimer Res. 2005, 2:377-385.
    • (2005) Curr. Alzheimer Res. , vol.2 , pp. 377-385
    • Perry, T.1    Greig, N.H.2
  • 248
    • 80054855642 scopus 로고    scopus 로고
    • Is the GLP-1 system a viable therapeutic target for weight reduction?
    • Tong J., Sandoval D.A. Is the GLP-1 system a viable therapeutic target for weight reduction?. Rev. Endocrinol. Metab. Disord. 2011, 12:187-195.
    • (2011) Rev. Endocrinol. Metab. Disord. , vol.12 , pp. 187-195
    • Tong, J.1    Sandoval, D.A.2
  • 249
    • 84860344189 scopus 로고    scopus 로고
    • Extending the reach of exendin-4: new pathways in the control of body weight and glucose homeostasis
    • Good D.J. Extending the reach of exendin-4: new pathways in the control of body weight and glucose homeostasis. Endocrinology 2012, 153:2051-2053.
    • (2012) Endocrinology , vol.153 , pp. 2051-2053
    • Good, D.J.1
  • 250
    • 33846032275 scopus 로고    scopus 로고
    • Gastrointestinal regulation of food intake
    • Cummings D., Overduin J. Gastrointestinal regulation of food intake. J. Clin. Invest. 2007, 117:13-23.
    • (2007) J. Clin. Invest. , vol.117 , pp. 13-23
    • Cummings, D.1    Overduin, J.2
  • 251
    • 84860325681 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding associated neuropeptides in hypothalamic neurons in vivo and in vitro
    • Dalvi P.S., Nazarians-Armavil A., Purser M.J., Belsham D.D. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding associated neuropeptides in hypothalamic neurons in vivo and in vitro. Endocrinology 2012, 153:2208-2222.
    • (2012) Endocrinology , vol.153 , pp. 2208-2222
    • Dalvi, P.S.1    Nazarians-Armavil, A.2    Purser, M.J.3    Belsham, D.D.4
  • 252
    • 33750093045 scopus 로고    scopus 로고
    • Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans
    • Pannacciulli N., Bunt J.C., Koska J., Bogardus C., Krakoff J. Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans. Am. J. Clin. Nutr. 2006, 84:556-560.
    • (2006) Am. J. Clin. Nutr. , vol.84 , pp. 556-560
    • Pannacciulli, N.1    Bunt, J.C.2    Koska, J.3    Bogardus, C.4    Krakoff, J.5
  • 253
    • 0031049302 scopus 로고    scopus 로고
    • Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man
    • Shalev A., Holst J.J., Keller U. Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man. Eur. J. Clin. Investig. 1997, 27:10-16.
    • (1997) Eur. J. Clin. Investig. , vol.27 , pp. 10-16
    • Shalev, A.1    Holst, J.J.2    Keller, U.3
  • 256
    • 0014188893 scopus 로고
    • Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects
    • Perley M.J., Kipnis D.M. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J. Clin. Invest. 1967, 46:1954-1962.
    • (1967) J. Clin. Invest. , vol.46 , pp. 1954-1962
    • Perley, M.J.1    Kipnis, D.M.2
  • 257
    • 0032908654 scopus 로고    scopus 로고
    • (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)
    • Young A.A., Gedulin B.R., Bhavsar S., Bodkin N., Jodka C., Hansen B., Denaro M. Glucose-lowering and insulinsensitizing actions of exendin-4: studies in obese diabetic. Diabetes 1999, 48:1026-1034.
    • (1999) Diabetes , vol.48 , pp. 1026-1034
    • Young, A.A.1    Gedulin, B.R.2    Bhavsar, S.3    Bodkin, N.4    Jodka, C.5    Hansen, B.6    Denaro, M.7
  • 258
    • 0026648961 scopus 로고
    • Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom
    • Eng J., Kleinman W.A., Singh L., Singh G., Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. J. Biol. Chem. 1992, 267:7402-7405.
    • (1992) J. Biol. Chem. , vol.267 , pp. 7402-7405
    • Eng, J.1    Kleinman, W.A.2    Singh, L.3    Singh, G.4    Raufman, J.P.5
  • 262
    • 0034218936 scopus 로고    scopus 로고
    • Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats
    • Al-Barazanji K.A., Arch J.R., Buckingham R.E., Tadayyon M. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats. Obes. Res. 2000, 8:317-323.
    • (2000) Obes. Res. , vol.8 , pp. 317-323
    • Al-Barazanji, K.A.1    Arch, J.R.2    Buckingham, R.E.3    Tadayyon, M.4
  • 263
    • 84856278537 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 regulation of carbohydrate intake is differentially affected byobesogenic diets
    • Pritchett C.E., Hajnal A. Glucagon-like peptide-1 regulation of carbohydrate intake is differentially affected byobesogenic diets. Obesity (Silver Spring) 2012, 20:313-317.
    • (2012) Obesity (Silver Spring) , vol.20 , pp. 313-317
    • Pritchett, C.E.1    Hajnal, A.2
  • 265
    • 77953726744 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 protects NSC-34 motor neurons against glucosamine through Epac-mediated glucose uptake enhancement
    • Lim J.G., Lee J.J., Park S.H., Park J.H., Kim S.J., Cho H.C., Baek W.K., Kim D.K., Song D.K. Glucagon-like peptide-1 protects NSC-34 motor neurons against glucosamine through Epac-mediated glucose uptake enhancement. Neurosci. Lett. 2010, 479:13-17.
    • (2010) Neurosci. Lett. , vol.479 , pp. 13-17
    • Lim, J.G.1    Lee, J.J.2    Park, S.H.3    Park, J.H.4    Kim, S.J.5    Cho, H.C.6    Baek, W.K.7    Kim, D.K.8    Song, D.K.9
  • 267
    • 24044493651 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects
    • Adam T.C., Westerterp-Plantenga M.S. Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects. Br. J. Nutr. 2005, 93:845-851.
    • (2005) Br. J. Nutr. , vol.93 , pp. 845-851
    • Adam, T.C.1    Westerterp-Plantenga, M.S.2
  • 272
    • 77953915094 scopus 로고    scopus 로고
    • Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor
    • Washington M.C., Raboin S.J., Thompson W., Larsen C.J., Sayegh A.I. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Brain Res. 2010, 1344:124-133.
    • (2010) Brain Res. , vol.1344 , pp. 124-133
    • Washington, M.C.1    Raboin, S.J.2    Thompson, W.3    Larsen, C.J.4    Sayegh, A.I.5
  • 276
    • 79960996273 scopus 로고    scopus 로고
    • Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia
    • Teramoto S., Miyamoto N., Yatomi K., Tanaka Y., Oishi H., Arai H., Hattori N., Urabe T. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2011, 31:1696-1705.
    • (2011) J. Cereb. Blood Flow Metab. , vol.31 , pp. 1696-1705
    • Teramoto, S.1    Miyamoto, N.2    Yatomi, K.3    Tanaka, Y.4    Oishi, H.5    Arai, H.6    Hattori, N.7    Urabe, T.8
  • 277
    • 0036312680 scopus 로고    scopus 로고
    • Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4
    • Tourrel C., Bailbe D., Lacorne M., Meile M.J., Kergoat M., Portha B. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 2002, 51:1443-1452.
    • (2002) Diabetes , vol.51 , pp. 1443-1452
    • Tourrel, C.1    Bailbe, D.2    Lacorne, M.3    Meile, M.J.4    Kergoat, M.5    Portha, B.6
  • 278
    • 38549162147 scopus 로고    scopus 로고
    • Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3years
    • Klonoff D.C., Buse J.B., Nielsen L.L., Guan X., Bowlus C.L., Holcombe J.H., Wintle M.E., Maggs D.G. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3years. Curr. Med. Res. Opin. 2008, 24:275-286.
    • (2008) Curr. Med. Res. Opin. , vol.24 , pp. 275-286
    • Klonoff, D.C.1    Buse, J.B.2    Nielsen, L.L.3    Guan, X.4    Bowlus, C.L.5    Holcombe, J.H.6    Wintle, M.E.7    Maggs, D.G.8
  • 279
    • 77955019118 scopus 로고    scopus 로고
    • Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis
    • Fan R., Li X., Gu X., Chan J.C., Xu G. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis. Diabetes Obes. Metab. 2010, 12:815-824.
    • (2010) Diabetes Obes. Metab. , vol.12 , pp. 815-824
    • Fan, R.1    Li, X.2    Gu, X.3    Chan, J.C.4    Xu, G.5
  • 280
    • 37349008890 scopus 로고    scopus 로고
    • Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial
    • Barnett A.H., Burger J., Johns D., Brodows R., Kendall D.M., Roberts A., Trautmann M.E. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Clin. Ther. 2007, 29:2333-2348.
    • (2007) Clin. Ther. , vol.29 , pp. 2333-2348
    • Barnett, A.H.1    Burger, J.2    Johns, D.3    Brodows, R.4    Kendall, D.M.5    Roberts, A.6    Trautmann, M.E.7
  • 283
    • 45549108268 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease
    • Harkavyi A., Abuirmeileh A., Lever R., Kingsbury A., Biggs C., Whitton P.S. Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease. J. Neuroinflammation 2008, 5:19.
    • (2008) J. Neuroinflammation , vol.5 , pp. 19
    • Harkavyi, A.1    Abuirmeileh, A.2    Lever, R.3    Kingsbury, A.4    Biggs, C.5    Whitton, P.S.6
  • 284
    • 33846501672 scopus 로고    scopus 로고
    • Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine induced peripheral sensory neuropathy
    • Perry T., Holloway H.W., Weerasuriya A., Mouton P.R., Duffy K., Mattison J.A., Greig N.H. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine induced peripheral sensory neuropathy. Exp. Neurol. 2007, 203:293-301.
    • (2007) Exp. Neurol. , vol.203 , pp. 293-301
    • Perry, T.1    Holloway, H.W.2    Weerasuriya, A.3    Mouton, P.R.4    Duffy, K.5    Mattison, J.A.6    Greig, N.H.7
  • 285
    • 79955749452 scopus 로고    scopus 로고
    • The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease
    • McClean P.L., Parthsarathy V., Faivre E., Hölscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J. Neurosci. 2011, 31:6587-6594.
    • (2011) J. Neurosci. , vol.31 , pp. 6587-6594
    • McClean, P.L.1    Parthsarathy, V.2    Faivre, E.3    Hölscher, C.4
  • 286
    • 0036721026 scopus 로고    scopus 로고
    • Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
    • Perry T., Haughey N.J., Mattson M.P., Egan J.M., Greig N.H. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J. Pharmacol. Exp. Ther. 2002, 302:881-888.
    • (2002) J. Pharmacol. Exp. Ther. , vol.302 , pp. 881-888
    • Perry, T.1    Haughey, N.J.2    Mattson, M.P.3    Egan, J.M.4    Greig, N.H.5
  • 287
    • 0038248960 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron
    • Perry T., Lahiri D.K., Sambamurti K., Chen D., Mattson M.P., Egan J.M., Greig N.H. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J. Neurosci. Res. 2003, 72:603-612.
    • (2003) J. Neurosci. Res. , vol.72 , pp. 603-612
    • Perry, T.1    Lahiri, D.K.2    Sambamurti, K.3    Chen, D.4    Mattson, M.P.5    Egan, J.M.6    Greig, N.H.7
  • 288
    • 16244388984 scopus 로고    scopus 로고
    • A randomized, open-label, crossover study examining the effect of injection site on bioavailability of exenatide (synthetic Exendin-4)
    • Calara F., Taylor K., Han J., Zabala E., Carr E.M., Wintle M., Fineman M. A randomized, open-label, crossover study examining the effect of injection site on bioavailability of exenatide (synthetic Exendin-4). Clin. Ther. 2005, 27:210-215.
    • (2005) Clin. Ther. , vol.27 , pp. 210-215
    • Calara, F.1    Taylor, K.2    Han, J.3    Zabala, E.4    Carr, E.M.5    Wintle, M.6    Fineman, M.7
  • 289
    • 77955470617 scopus 로고    scopus 로고
    • Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet
    • Gault V.A., Porter W.D., Flatt P.R., Holscher C. Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. Int. J. Obes. 2010, 34:1341-1344.
    • (2010) Int. J. Obes. , vol.34 , pp. 1341-1344
    • Gault, V.A.1    Porter, W.D.2    Flatt, P.R.3    Holscher, C.4
  • 290
    • 34247195226 scopus 로고    scopus 로고
    • A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
    • Nauck M.A., Duran S., Kim D., Johns D., Northrup J., Festa A., Brodows R., Trautmann M. A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 2007, 50:259-267.
    • (2007) Diabetologia , vol.50 , pp. 259-267
    • Nauck, M.A.1    Duran, S.2    Kim, D.3    Johns, D.4    Northrup, J.5    Festa, A.6    Brodows, R.7    Trautmann, M.8
  • 291
    • 53249142132 scopus 로고    scopus 로고
    • Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
    • for the DURATION-1 Study Group
    • Drucker D.J., Buse J.B., Taylor K., Kendall D.M., Trautmann M., Zhuang D., Porter L. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 2008, 372:1240-1250. for the DURATION-1 Study Group.
    • (2008) Lancet , vol.372 , pp. 1240-1250
    • Drucker, D.J.1    Buse, J.B.2    Taylor, K.3    Kendall, D.M.4    Trautmann, M.5    Zhuang, D.6    Porter, L.7
  • 292
    • 33646264519 scopus 로고    scopus 로고
    • Improving patient adherence
    • Delamater A.M. Improving patient adherence. Clin. Diabetes 2006, 24:71-77.
    • (2006) Clin. Diabetes , vol.24 , pp. 71-77
    • Delamater, A.M.1
  • 293
    • 44449148293 scopus 로고    scopus 로고
    • The impact of medication regimen factors on adherence to chronic treatment: a review of the literature
    • Ingersoll K.S., Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of the literature. J. Behav. Med. 2008, 31:213-224.
    • (2008) J. Behav. Med. , vol.31 , pp. 213-224
    • Ingersoll, K.S.1    Cohen, J.2
  • 294
    • 57649232757 scopus 로고    scopus 로고
    • Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    • Russell-Jones D. Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue. Mol. Cell. Endocrinol. 2009, 297:137-140.
    • (2009) Mol. Cell. Endocrinol. , vol.297 , pp. 137-140
    • Russell-Jones, D.1
  • 295
    • 0025717816 scopus 로고
    • The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
    • Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1991, 1:103-116.
    • (1991) Cereb. Cortex , vol.1 , pp. 103-116
    • Arnold, S.E.1    Hyman, B.T.2    Flory, J.3    Damasio, A.R.4    Van Hoesen, G.W.5
  • 296
    • 84869090452 scopus 로고    scopus 로고
    • Liraglutide protects against amyloid-β protein induced impairment of spatial learning andmemory in rats
    • (Electronic publication ahead of print)
    • Han W.N., Hölscher C., Yuan L., Yang W., Wang X.H., Wu M.N., Qi J.S. Liraglutide protects against amyloid-β protein induced impairment of spatial learning andmemory in rats. Neurobiol. Aging 2013, 34:576-588. (Electronic publication ahead of print).
    • (2013) Neurobiol. Aging , vol.34 , pp. 576-588
    • Han, W.N.1    Hölscher, C.2    Yuan, L.3    Yang, W.4    Wang, X.H.5    Wu, M.N.6    Qi, J.S.7
  • 297
    • 84858713174 scopus 로고    scopus 로고
    • Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
    • Hunter K., Holscher C. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci. 2012, 13:33-38.
    • (2012) BMC Neurosci. , vol.13 , pp. 33-38
    • Hunter, K.1    Holscher, C.2
  • 298
    • 33745591621 scopus 로고    scopus 로고
    • Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent
    • Brinton R.D., Wang J.M. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr. Alzheimer Res. 2006, 3:185-190.
    • (2006) Curr. Alzheimer Res. , vol.3 , pp. 185-190
    • Brinton, R.D.1    Wang, J.M.2
  • 300
    • 77956134398 scopus 로고    scopus 로고
    • Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance
    • Porter D.W., Kerr B.D., Flatt P.R., Holscher C., Gault V.A. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diabetes Obes. Metab. 2010, 12:891-899.
    • (2010) Diabetes Obes. Metab. , vol.12 , pp. 891-899
    • Porter, D.W.1    Kerr, B.D.2    Flatt, P.R.3    Holscher, C.4    Gault, V.A.5
  • 302
    • 84877575636 scopus 로고    scopus 로고
    • Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice
    • ( Jun 5, Electronic publication ahead of print)
    • Porter W.D., Flatt P.R., Hölscher C., Gault V.A. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice. Int. J. Obes. (Lond.) 2012, ( Jun 5, Electronic publication ahead of print). 10.1038/ijo.2012.91.
    • (2012) Int. J. Obes. (Lond.)
    • Porter, W.D.1    Flatt, P.R.2    Hölscher, C.3    Gault, V.A.4
  • 303
    • 79960741385 scopus 로고    scopus 로고
    • Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4
    • Kanoski S.E., Fortin S.M., Arnold M., Grill H.J., Hayes M.R. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology 2011, 152:3103-3112.
    • (2011) Endocrinology , vol.152 , pp. 3103-3112
    • Kanoski, S.E.1    Fortin, S.M.2    Arnold, M.3    Grill, H.J.4    Hayes, M.R.5
  • 304
    • 34248223285 scopus 로고    scopus 로고
    • Biology of incretins: GLP-1 and GIP
    • Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
    • (2007) Gastroenterology , vol.132 , pp. 2131-2157
    • Baggio, L.L.1    Drucker, D.J.2
  • 305
    • 0036035521 scopus 로고    scopus 로고
    • Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans
    • Vella A., Shah P., Reed A.S., Adkins A.S., Basu R., Rizza R.A. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans. Diabetologia 2002, 45:1410-1415.
    • (2002) Diabetologia , vol.45 , pp. 1410-1415
    • Vella, A.1    Shah, P.2    Reed, A.S.3    Adkins, A.S.4    Basu, R.5    Rizza, R.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.